The European Commission is preparing to open an in-depth investigation into Ikea’s corporate tax structure.
The Commission said Dutch-based Inter Ikea, one of the Swedish giant’s two divisions, may have been given unfair tax advantages by the Netherlands.
European Competition Commissioner Margrethe Vestager said all firms “big or small, multinational or not, should pay their fair share of tax.”
The Commission will look at whether Ikea’s tax affairs breach EU rules on state aid.
Under EU law, member states cannot give selective tax benefits to multinational groups that are not available to other firms.
“The Commission has concerns that two [Dutch] tax rulings may have given Inter Ikea Systems an unfair advantage compared to other companies,” the regulator said.
The move is the latest crackdown by the EU competition authority on tax deals between EU countries and multinationals.
A spokesman for Inter Ikea Group said the way it had been taxed “has in our view been in accordance with EU rules. It is good if the investigation can bring clarity and confirm that,” he added.
Full Content: The New York Times
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Federal Judge Signals Revisions Likely in DOJ Case Targeting Live Nation Monopoly
Jan 22, 2025 by
CPI
American Airlines and JetBlue Agree to $2 Million Legal Fee Settlement with U.S. States
Jan 22, 2025 by
CPI
Federal Judge Dismisses Class Action Alleging Inflated Yacht Commission Fees
Jan 22, 2025 by
CPI
Doug Gurr Appointed Interim Chairman of UK’s Competition Authority
Jan 22, 2025 by
CPI
LinkedIn Faces Lawsuit Over Alleged Misuse of Customer Data for AI Training
Jan 22, 2025 by
Amanda Adams
Antitrust Mix by CPI
Antitrust Chronicle® – Pharmacy Benefit Managers
Jan 20, 2025 by
CPI
Untangling the PBM Mess
Jan 20, 2025 by
Kent Bernard
Using Data, Not Anecdotes, to Analyze Criticisms of Pharmacy Benefit Managers
Jan 20, 2025 by
Dennis Carlton
Vertical Integration and PBMs: What, Me Worry?
Jan 20, 2025 by
Lawton Robert Burns & Bradley Fluegel
The Economics of Benefit Management in Prescription-Drug Markets
Jan 20, 2025 by
Casey B. Mulligan